Home | HIV Information | Expert Available For Comment: CMS To Cover Injections For HIV-Associated Facial Lipoatrophy

Expert Available For Comment: CMS To Cover Injections For HIV-Associated Facial Lipoatrophy

30 March, 2010 07:00:00 Medical News Today
Font size: Decrease font Enlarge font
In a landmark decision, the Centers for Medicare & Medicaid Services (CMS) has announced it will now cover the use of FDA-approved dermal fillers for the treatment of HIV-associated facial lipoatrophy (LA), severely hollowed cheeks and changes to the face's appearance resulting from HIV treatments...

Comments (0 posted):

Post your comment comment

Please enter the code you see in the image:

  • email Email to a friend
  • print Print version
  • Plain text Plain text
Tags
No tags for this article
Rate this article
0
Powered by Vivvo CMS v4.0